Some indices of haemostasis during Lewis lung carcinoma growth

Experimental Oncology

Volumn 23, Issue 1, 2001, Pages 73-75

  Petik, A V ^a   Platonova, T N ^a   Andrianov, S I ^a   Pyaskovskaya, O N ^b   Savchuk, A N ^a   Lukinova, N I ^a   Yakovlev, S A ^a   Chekhun, V F ^b  

^a PALLADIN INSTITUTE OF BIOCHEMISTRY   (Ukraine)

^b R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

Author keywords

Fibrinogen; Lewis lung carcinoma; Plasminogen activator inhibitors

Indexed keywords

EID: 0012792645     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. van Bodegraven AA, Schoorl M, Baak JP, Linskens RK, Bartels PC, Tuynman HA. Hemostatic imbalance in active and quiescent ulcerative colitis. Am J Gastroenterol 2001; 96: 487-93.
2. Tohgi H, Konno S, Takahashi S, Koizumi D, Kondo R, Takahashi H. Activated coagulation/fibrinolysis system and platelet function in acute thrombotic stroke patients with increased C-reactive protein levels. Thromb Res 2000; 100: 373-9.
3. Letai A, Kuter DJ. Cancer, coagulation and anticoagulation. Oncologist 1999; 4: 443-9.
4. Tripodi A, Mannucci PM, Chantarangkul V, Bottasso B, Arbini AA, Della Bella S, Scorza. R Markers of procoagulant imbalance in patients with localized melanomas and autoimmune disorders. Br J Haematol 1993; 84: 670-4.
5. Rahr HB, Sorensen JV, Larsen JF, Jensen FS, Bredahl C. Markers of coagulation and fibrinolysis in portal blood from patients with and without gastric malignancy. Scand J Gastroenterol 1994; 29: 516-21.
6. Abbasciano V, Tassinari D, Sartori S, Trevisani L, Arcudi D, Blanchi MP, Liboni A. Usefulness of coagulation markers in staging of gastric cancer. Cancer Detect Prev 1995; 19: 331-6.
7. Abbasciano V, Bianchi MP, Trevisani L, Sartori S, Gilli G, Zavagli G. Platelet activation and fibrinolysis in large bowel cancer. Oncology 1995; 52: 381-4.
8. Kalweit GA, Feindt P, Micek M, Gams E, Hellstern P. Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood. Thromb Res 2000; 97: 105-11.
9. Lopez Y, Paloma MJ, Rifon J, Cuesta B, Paramo JA. Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states. Thromb Res 1999; 93: 71-8.
10. Oberhoff C, Rollwagen C, Tauchert AM, Hoffmann O, Winkler UH, Schindler AE. Perioperative development of a thrombogenic risk profile in patients with carcinomas of the breast: a cause of increased thrombosis. Eur J Gynaecol Oncol 2000; 21: 560-8.
11. Wojtukiewicz MZ, Rucinska M, Zimnoch L, Jaromin J, Piotrowski Z, Rozanska-Kudelska M, Kisiel W, Kudryk BJ. Expression of prothrombin fragment 1+2 in cancer tissue as an indicator of local activation of blood coagulation. Thromb Res 2000; 97: 335-42.
12. Druzhyna NN, Makogonenko EM, Yakovlev AY. Studies of the t-PA-catalyzed glu-plasminogen activation on different models of polymeric fibrin. Thromb Res 1997; 87: 131-9.
13. Eriksson E, Ranby M, Gyzander E, Risberg B. Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay. Thromb Res 1988; 50: 91-101.
14. Okugawa Y, Wada H, Noda T, Sakakura M, Nakasaki T, Watanabe R, Deguchi H, Gabazza EC, Mori Y, Nishikawa M, Deguchi K, Nobori T, Shiku H. Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation. Am J Hematol 2000; 65: 210-4.
15. Mac Gillavry MR, Sanson BJ, de Monye W, Lijmer JG, Huisman MV, Buller HR, Nieuwenhuizen W, Brandjes DP. Use of a new monoclonal antibody-based enzyme immunoassay for soluble fibrin to exclude pulmonary embolism. ANTELOPE-Study Group. Thromb Haemost 2000; 84: 474-7.
16. Yamaguchi T, Yamamoto Y, Yokota S, Nakagawa M, Ito M, Ogura T. Involvement of interleukin-6 in the elevation of plasma fibrinogen levels in lung cancer patients. Jpn J Clin Oncol 1998; 28: 740-4.
17. Johnson MJ, Wallker ID, Sproule MW, Conkie J. Abnormal coagulation and deep venous thrombosis in patients with advanced cancer. Clin Lab Haematol 1999; 21: 51-4.